Epilepsy Center
11 – 20 of 170
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Injectable bioresorbable conductive hydrogels for multimodal brain tumor electroimmunotherapy
- Contribution to journal › Article
-
Mark
Authors’ reply to Chaker Ben Salem’s comment on : “Drug-Induced Cognitive Impairment”
- Contribution to journal › Letter
-
Mark
Personality Trait Changes After Device-Aided Therapy : Insights From Parkinson’s Patients and Their Close Relatives
- Contribution to journal › Article
-
Mark
Disorders of Glycosylation
(2025) p.3-572
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
AAV-mediated gene therapy for focal epilepsy by expressing neuropeptide Y and Y2 receptor in rodent and non-human primate hippocampus
- Contribution to journal › Article
-
Mark
Dose-Dependent Effects of Myo-Inositol on Kainic Acid-Induced Epilepsy : Electrophysiological, Behavioral, Transcriptomic, and DNA Methylome Studies
- Contribution to journal › Article
-
Mark
Cognitive outcomes of infusion therapies in Parkinson's disease : A comprehensive systematic review
- Contribution to journal › Scientific review
-
Mark
Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistance
- Contribution to journal › Article
-
Mark
Noninvasive MGMT-promotor methylation prediction in high grade gliomas using conventional MRI and deep learning-based segmentations
- Contribution to journal › Article
-
Mark
Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype : study protocol for a randomized double-blind placebo-controlled trial
- Contribution to journal › Article
